You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 72 No. 5, November 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ocular Toxoplasmosis

MICHAEL J. HOGAN, MD; SAMUEL J. KIMURA, MD; G. RICHARD O'CONNOR, MD

Arch Ophthalmol. 1964;72(5):592-600.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Ocular toxoplasmosis is a recognized clinical entity. However, proof of the existence of a toxoplasmic eye infection is difficult to establish because: (1) isolation of this organism is rarely possible except from the enucleated eye, or from aspirated aqueous or subretinal fluid; (2) acute systemic infection preceding or associated with the acute eye disease occurs in less than 1% of cases; and (3) serologic and skin test studies reveal only the presence of antibody and do not indicate activity, except in unusual cases.

The evidence that toxoplasmosis affecting the retina and choroid exists with some frequency is as follows: (1) histologic studies after enucleation of inflamed and glaucomatous eyes have revealed this parasite in a considerable number of instances; (2) isolations of Toxoplasma have been made from enucleated eyes in a few instances, and from aqueous and subretinal fluid in rare cases; (3) concomitant systemic and eye involvement with . . . [Full Text PDF of this Article]


Author Affiliations

San Francisco

From the Francis I. Proctor Foundation and the Department of Ophthalmology, University of California School of Medicine.


Footnotes

Read before the Section on Ophthalmology, at the 113th Annual Meeting of the American Medical Association, San Francisco, June, 1964.

This work was supported in part by research grants NB-0786, NB-00044, NB-01099, National Institute of Neurological Diseases and Blindness, National Institutes of Health, Bethesda, Md.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.